The latest price target for Passage Bio (NASDAQ:PASG) was reported by Chardan Capital on March 4, 2025. The analyst firm set a price target for $6.00 expecting PASG to rise to within 12 months (a ...

Review quarterly and annual revenue, net income, and cash flow for Passage Bio Inc Ordinary Shares (PASG:XNAS) stock through the last fiscal year.

View the latest Passage Bio Inc. (PASG) stock price, news, historical charts, analyst ratings and financial information from WSJ.